| Literature DB >> 32954022 |
Zhengzheng Jiang1, Xulin Hong1, Shun Zhang1, Ruilian Yao1,2, Yi Xiao1,2.
Abstract
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR associated) has been extensively exploited as a genetic tool for genome editing. The RNA guided Cas nucleases generate DNA double-strand break (DSB), triggering cellular repair systems mainly Non-homologous end-joining (NHEJ, imprecise repair) or Homology-directed repair (HDR, precise repair). However, DSB typically leads to unexpected DNA changes and lethality in some organisms. The establishment of bacteria and plants into major bio-production platforms require efficient and precise editing tools. Hence, in this review, we focus on the non-DSB and template-free genome editing, i.e., base editing (BE) and prime editing (PE) in bacteria and plants. We first highlight the development of base and prime editors and summarize their studies in bacteria and plants. We then discuss current and future applications of BE/PE in synthetic biology, crop improvement, evolutionary engineering, and metabolic engineering. Lastly, we critically consider the challenges and prospects of BE/PE in PAM specificity, editing efficiency, off-targeting, sequence specification, and editing window.Entities:
Keywords: Adenine base editor; Base editing; CRISPR; Cytosine base editor; Prime editing
Year: 2020 PMID: 32954022 PMCID: PMC7481536 DOI: 10.1016/j.synbio.2020.08.003
Source DB: PubMed Journal: Synth Syst Biotechnol ISSN: 2405-805X
Fig. 1Deaminase based Cas9 base editing. A schematic model of deaminase based Cas9 base editing systems: cytosine base editors (CBE, for example, BE3 & Target-AID) and adenine base editor (ABE). CBE consists of rat apolipoprotein B mRNA editing enzyme (APOBEC), and uracil glycosylase inhibitor (UGI) fused to N and C terminus of nCas9(D10A), respectively. Target-AID consists of activation-induced cytosine deaminase ortholog PmCDA1 and UGI fused to N terminus of nCas9(D10A). CBE involves deamination of cytosine by the deaminase which converts it into uracil, making U•G wobble base. UGI prevents its conversion back to C. Mismatch repair machinery (MMR) recognizes it forming U•A which is then converted to T•A by replication machinery leading C•G-to-T•A substitution. ABE consists of heterodimeric wtTadA-TadA* fused to nCas9(D10A). ABE performs deamination converting T•A-to-T•I which is then recognized by DNA repair and replication machinery and converted to C•G base pair (Yellow triangle: nick site).
Fig. 2Schematic representation of prime editing system. (A) The basic construct of PE consists of nCas9(H840A) fused to reverse transcriptase (RT) via a linker. The prime guide RNA (pegRNA) in PE consists of gRNA, primer binding site (PBS) and RT template. Once nCas9(H840A) nicks the strand, RT uses PBS fused to 3′ flap as a primer to encode RT DNA template. (B) After reverse transcription, PE1 and PE2 systems involve flap equilibrium of edited 3′ and unedited 5′ flap. The unedited 5′ flap is then cleaved off by structure-specific endonucleases followed by ligation and DNA repair/replication leading to permanent editing (Green bases: pegRNA binding regions, Red bases: desired edits). (C) After 5′ flap cleavage, a heteroduplex of the edited and unedited strand is formed. PE3 and PE3b involve a 2nd nick in the unedited strand 14-116 nt away from the initial pegRNA nick. This increases the chances of generation of dsDNA with the desired edit by favouring the repair of unedited strand by repair/replication machinery (Black strand: original DNA, Red strand: edited strand, Yellow triangle: nick site).
Base editing systems in bacteria.
| Organism | Editor type | Base editing system | Target genes | Editing efficiency | Editing window (upstream of PAM) | Ref. |
|---|---|---|---|---|---|---|
| BE3 | pEcBE3 | 100% | −12 to −16 | [ | ||
| Target-AID | dCas9-CDA-UL | 61–95% | −16 to −20 (extended sgRNA = −18 to −24) | [ | ||
| Cpf1-based BE | dLB-Cpf1-BE | 45–80% | −7 to −13 (downstream of PAM) | [ | ||
| ABE | pABE | 66–100% | −13 to −17 | [ | ||
| ABE | pnCas9-TadA | 9.3–65.4% | −12 to −17 | [ | ||
| pdCas9-TadA | 1.3–8.3% | |||||
| pnCas9-TadA + Cas9 | 12.7–99% | |||||
| Target-AID | dCas9-CDA-ULstr | 50–100%, | −16 to −20 | [ | ||
| BE3 | CRISPR-cBEST | actinorhodin gene cluster, CDA gene cluster, RED gene cluster | 30–100% | −11 to −17 | [ | |
| BE2 | BE2 | 43–70% | −13 to −17 | [ | ||
| BE3 | BE3 | 100% | −13 to −17 | [ | ||
| 0–100% multiplex editing | ||||||
| HF-BE3 | HF-BE3 | 60–80% | −13 to −17 | [ | ||
| ABE | CRISPR-aBEST | 0–40% | −12 to −17 | [ | ||
| ABE | ABEd | – | −14 to −17 | [ | ||
| ABE | ABEn | 100% | −14 to −17 | [ | ||
| BE3 | pWHU77-BE | – | – | [ | ||
| BE3 | pnCasSA-BEC | 100% | −13 to −17 | [ | ||
| ABE | pABE | 50–100% | −13 to −17 | [ | ||
| BE3 | pnCasPA-BEC | >90% | −13 to −18 | [ | ||
| >90% | ||||||
| >84% | ||||||
| >90% | ||||||
| BE3 | pBECKP | 25–100% | −13 to −18 | [ | ||
| BE3 | pCBEclos-opt | 40–100% | – | [ | ||
| BE3 | BE3 | 100% | – | [ | ||
| Target-AID | CRISPR/dCas9-AID | 11.2% | – | [ | ||
| CRISPR/nCas9(D10A)-AID | >48%, | −16 to −20 | ||||
Base editing system refers to the specific name of the editor used in the specific papers.
Dual loci targeting efficiency.
Triple loci targeting efficiency.
Base editing and prime editing systems in plants.
| Organism | Editor type | Base editing system | Target genes | Editing frequency | Editing window (upstream of PAM) | Ref. |
|---|---|---|---|---|---|---|
| BE3 | pnCas9-PBE | 43.48 | −18 to −12 | [ | ||
| BE2 | APOBEC1-XTEN-Cas9(D10A) | ≤13.3% | −17 to −14 | [ | ||
| BE3 | APOBEC1-XTEN-Cas9n-UGI-NLS | 10–38.9% | −19 to −13 | [ | ||
| BE4 | APOBEC1-XTEN-Cas9n (VQR)-UGI-NLS | 18.2% | −19 to −13 | |||
| Target-AID | nCas9Os-PmCDA1At | 6–89% | −19 to −17 | [ | ||
| ABE | PABE | 3.2–59.1% | −17 to −13 | [ | ||
| ABE | TadA-TadA7.10-Cas9n | 0–62.26% | −17 to −14 | [ | ||
| ABE | pRABEsp-OsU6 | >4.8% | −17 to −14 | [ | ||
| ABE | pRABESA-OsU6sa | >17% | – | |||
| ABE | pHUN411-ABE | <10% | −16 to −12 | [ | ||
| APOBEC3A | A3A-PBE | 44–83% | −20 to −4 | [ | ||
| hAID∗Δ | hAID∗Δ-XTEN-Cas9n-NLS | – | −18 to −14 | [ | ||
| ABE | VQR-Cas9 (D10A)/VRER-Cas9 (D10A) | ≤74.3% | −19 to −11 | [ | ||
| ABE | SaKKH-Cas9 (D10A) | 6.5% | – | |||
| BE | VQR-Cas9 (D10A) | ≤61.1% | – | |||
| BE3 | xCas9(D10A)-rAPOBEC1 | ≤30% | −19 to −16 | [ | ||
| Target-AID | xCas9(D10A)-PmCDA1 | <20% | −19 to −16 | |||
| Target-AID | Cas9-NG (D10A)-PmCDA-UGI | 0–56.3% | −20 to −7 | |||
| Target-AID | NGv1 (D10A) | 5–95.5% | −20 to −9 | [ | ||
| BE | NGv1 (D10A) | 4.3–21.8% | −19 to −14 | |||
| BE3 | pCXUN-BE3 | 0.1–20% | −17 to −13 | [ | ||
| BE3 | eBE3, eCDA, eABE | – | – | [ | ||
| BE3 | Base-Editing-mediated Gene Evolution (BEMGE) | – | – | [ | ||
| BE3 | xCas9-epBE | 5–64.3% | −20 to −10/-7 | [ | ||
| BE4 | xCas9n-CBE, Cas9n-NG-CBE, eCas9n-NG-CBE | 9.1–45.5% | −18 to −13 | [ | ||
| ecTadA∗7.10-nCas9 | ABE-P1S | 11.4–96.3% | −20 to −9 | [ | ||
| ecTadA∗7.10-nSaCas9, | ABE-P2S | 15.9–61.1% | −20 to −18 | |||
| ecTadA∗7.10-nSaKKH-Cas9 | ABE-P5S | 6.1–33.9% | −17 to −10 | |||
| BE3 | nCas9-PBE | 58–68% | −18 to −12 | [ | ||
| ABE | ABE7.10-nSpCas9-NGv1 | 29.2–45.8% | −16 to −13 | [ | ||
| ABE | pPUN411-HABE, pPUN411-ABEH | >97.9% | – | [ | ||
| PE | PPE2, PPE3, PPE3b | ≤21.8% | – | [ | ||
| PE | pPE2, pPE3, pPE3b | 0–31.3% | – | [ | ||
| PE | PE-P1, PE-P2 | ≤26% | – | [ | ||
| PE | pCXUN-Ubi-NLS-nCas9(H840A)-Linker1 (33aa)-M-MLV-RT-Linker2 (14aa)-NLS-PolyA-E9-Actin-Nos | 2.22–9.38% | – | [ | ||
| PE | Sp-PE2, Sp-PE3, Sa-PE3 | 0–17.1% | – | [ | ||
| BE3 | pnCas9-PBE | 1.25% | −18 to −12 | [ | ||
| ABE | PABE | 0.4–1.1% | −17 to −13 | [ | ||
| APOBEC3A | A3A-PBE | 16.7–22.5% | −20 to −4 | [ | ||
| BE3 | PBE | 33–75% | −18 to −12 | [ | ||
| BE3 | pnCas9-PBE | 10% | −18 to −12 | [ | ||
| Target-AID | nCas9At-PmCDA1Hs/nCas9At-PmCDA1At | 41–92% | −20 to −18 | [ | ||
| Target-AID | pDeSpnCas9-NG_PmCDA1_UGI | 32% | −20 to −13 | [ | ||
| Target-AID | pDeSpnCas9-NG_PmCDA1_UGI | 9–64% | −18 to −16 | |||
| APOBEC3A | pDeSpnCas9-NG_hAPOBEC3A_PmCDA1_UGI | 8–42% | −18 to −11 | |||
| APOBEC3A | A3A-PBE | 6.5% | −20 to −4 | [ | ||
| Target-AID | – | 100% | – | [ | ||
| ABE | pcABEs | 0–85% | −16 to −12 | [ | ||
| BE3 | BE3 | 2.7–40% | −17 to −12 | [ | ||
| BE3 | nCas9-PBE | 39.3% | −18 to −12 | [ | ||
| BE3 | BE3 | 50% | – | [ | ||
| ABE | pcABEs | 8.8% | −16 to −12 | [ | ||
| BE3 | CBE3 | 23% | −14 to −13 | [ | ||
| BE3 | GhBE3 | 26–58% | −17 to −12 | [ | ||
| BE3 | pTF101.1-sgRNA-BE | ≤18.2% | – | [ | ||
| BE3 | CBE | 1.8% | – | [ |
Base editing system refers to the specific name of the editor in the specific papers.
Editing frequency refers to the ratio of edited to unedited plants.
Agrobacterium mediated system.
Particle bombardment.
Protoplast transformation.
Efficiency in targeted sequence.
Fig. 3Base editing and Prime editing applications (current & future). (A) Molecular recorders use BE to carry out nucleotide substitution relative to a specific stimulus. The base editing takes place in the presence of an external signal. The output signal either be phenotypic which can be recorded in the real-time or genotypic read via sequencing. DNA-writing technology can be expanded by the incorporation of PEs. (B) BE and PE can play a critical role in crop improvement. It has already been used for herbicide and disease resistance and trait improvement. (C) Artificial evolution can be achieved by BE/PE via the development of sgRNA/pegRNA libraries. UGI deprived CBE can lead to versatile mutations like C-to-G and C-to-A, this ability can be exploited for direct protein evolution. (D) Metabolic engineering in plants and bacteria can be improved by enhancing the enzymatic activity and deleting the competitive pathways by BE/PE tools.